July 2022 "Today we are celebrating ten years of Exscientia ! Founded as a spinout from the University of Dundee on 20 July 2012, Exscientia pioneered the design of novel compounds through artificial intelligence. We have achieved a great deal in the last decade, such as the first-ever AI-designed drug candidates to enter clinical trials, the first AI-driven precision medicine platform clinically validated to guide treatment selection in patients with advanced haematological cancers, international partnerships with pharma and healthcare foundations, and the establishment of a global company with locations in the UK, U.S., Austria, and Japan which IPO’d in October last year. We’re excited about delivering the next ten years of Exscientia and advancing AI to design better drugs, faster. #artificialintelligence #drugdesign #drugdiscovery" Read more at the source #DrGPCR #GPCR #IndustryNews

July 2022 " G.CLIPS biotech is 2 years old today🎂.

fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old

Don't tell the same old story you've already told. If you'd like to add new insight to an old experience, just edit your review instead of creating a new

Single-cell RNA sequencing on long-bone stromal cells of 9-wk-old male ColI(2.3)+/Rs1+ mice and littermate

particular social group or religion, offensive or harassing; and (iv) you are eighteen (18) years of age or older